<p>Today we will be discussing a few of the exciting abstracts presented at ASCO GU (Feb 13-15 2025) for prostate CA (TALAPRO-2), bladder CA (EV-302, CM-274, NIAGARA), and RCC (COSMIC-313, KIM-1).</p>

Today we will be discussing a few of the exciting abstracts presented at ASCO GU (Feb 13-15 2025) for prostate CA (TALAPRO-2), bladder CA (EV-302, CM-274, NIAGARA), and RCC (COSMIC-313, KIM-1).

ASCO GU 2025 Takeaways

This is Sam and Karine, and we are Two Onc Docs! We both graduated from our Heme/Onc fellowships in 2021 and became board certified in both Hematology and Oncology. Our mission with Two Onc Docs is to create short board review episodes that you can listen to on your drive to work, while you make your morning coffee, or between pages on call. This is intended to be a supplement to other established board studying resources for busy trainees. *This podcast is intended to be an educational resource for health care providers.*

Share ASCO GU 2025 Takeaways

Sign up to save your podcasts

ASCO GU 2025 Takeaways

ASCO GU 2025 Takeaways

More shows like Two Onc Docs

NEJM This Week

Research To Practice | Oncology Videos

JAMA Clinical Reviews

ASCO Daily News

The Curbsiders Internal Medicine Podcast

Core IM | Internal Medicine Podcast

The ONS Podcast

OncoPharm

ASCO Guidelines

Plenary Session

The Clinical Problem Solvers

Oncology Today with Dr Neil Love

The Curious Clinicians

Blood Cancer Talks

Oncology Brothers: Practice-Changing Cancer Discussions